Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 4.6B | 8.2B | 4.8B |
Cost of revenue | 3.2B | 2.7B | 5.1B | 2.4B |
Gross profit | 2.7B | 1.9B | 3.1B | 2.4B |
Operating expense | ||||
Research & development | 296.2M | 284.8M | 252.8M | 272.9M |
Selling general and admin | 285.9M | 289.0M | 269.5M | 251.7M |
Other operating expenses | 169.4M | 95.7M | 80.5M | 145.8M |
Operating income | 2.0B | 1.2B | 2.5B | 1.8B |
Non operating interest income | ||||
Income | 65.8M | 102.6M | 79.7M | 122.7M |
Expense | 49.9M | 51.8M | 59.2M | 49.0M |
Other income expense | -67.2M | -73.5M | -77.2M | -44.7M |
Pretax income | 1.9B | 1.2B | 2.4B | 1.8B |
Tax provision | 56.0M | 40.9M | 289.4M | 78.2M |
Net income | 1.9B | 1.1B | 2.1B | 1.7B |
Basic EPS | — | 1.0 | 1.8 | 1.5 |
Diluted EPS | — | 1.0 | 1.8 | 1.5 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 2.7B | 2.0B | 3.2B | 2.5B |
Net income from continuing op. | 1.9B | 1.1B | 2.1B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |